Search results
Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 7 days agoThe financial overview indicates that LLY has experienced revenue growth driven by increased volume...
ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook
Zacks via Yahoo Finance· 6 days agoEli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity...
Rybelsus vs. Ozempic: How These Drugs Compare
Healthline· 6 days agoRybelsus (semaglutide) and Ozempic (semaglutide) are prescription drugs used to treat type 2 diabetes. Rybelsus comes as an oral tablet, while Ozempic comes as an injectable liquid solution.
IBD Stock Of The Day Eli Lilly Surges After Weight-Loss Drug Obliterates Sales Views
Investor's Business Daily· 7 days agoHe kept his in-line (neutral) rating on Eli Lilly stock. Sales of other key products, cancer drug...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 4 days agoLilly’s first-quarter results were soft as it beat estimates for earnings but missed the same for...
May 1, 2024, Letters to the Editor
The Record-Courier· 7 days agoZephyr Cove Resort previously leased from the Forest Service about a half mile of lakefront. Despite public objections, the Forest Service has now agreed...
Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoEli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript April 30, 2024 Eli Lilly and...
Unpacking the Latest Options Trading Trends in Eli Lilly and Co - Eli Lilly and Co (NYSE:LLY)
Benzinga· 5 days agoLilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. Current ...
These 3 Companies Recently Lifted Guidance
Zacks via Yahoo Finance· 7 days agoRevenue throughout the period grew 26% year-over-year, driven by strong demand within Mounjaro, Zepbound, Verzenio, and Jardiance. The results impressed...
Eli Lilly and Company (NYSE:LLY) Trading 2.6% Higher After Strong Earnings
ETF DAILY NEWS· 18 hours agoEli Lilly and Company (NYSE:LLY – Get Free Report) shares rose 2.6% during trading on Monday following a stronger than expected earnings report. Eli Lilly and Company had a return on equity ...
